Genzyme, Voyager in CNS gene therapy tie-up

Voyager Therapeutics Inc. (Cambridge, Mass.) and the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY) partnered to develop and commercialize Voyager's

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE